Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug Conjugate(ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • Medicilon Inhalation Formulation R&D Platform
      • Preclinical Ophthalmic Research Platform
      • mRNA Vaccine Bioanalysis Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • Medicilon Inhalation Formulation R&D Platform
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
      • Medicilon Metabolite Identification (MetlD) Service Platform
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Generics Consistency Evaluation

Home Service Generics Consistency Evaluation

Generic Medicine Evaluation of Consistency Quality Services

  • Quality Comparison of the Preparations and Generic Drugs
  • Prescription Technology Redevelopment Services
  • Animal BE Service

Medicilon Provide Generic Drug Quality Consistency Workflow

  • Determine the Reference Formulation
  • Method of Determining Key Indicators
  • Comprehensive Comparison between Reference and Generic Drugs
  • Re-development of Prescription and Manufacture Process
  • Pilot Production Scale Up, Production Technology Transfer
  • Animal BE Services (Optional)
  • Data Collation
Contact Us

Share

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

  • Medicilon's Formulation
  • Medicilon Formulation
  • Medicilon Formulation Lab
  • Medicilon Formulation Equipment
  • Medicilon Drug Formulation
  • Formulation
  • Formulation Medicilon

You May Also Like

  • Integrated Projects

    Integrated Projects

    Integrated Projects

  • Drug Safety Evaluation

    Drug Safety Evaluation

    Drug Safety Evaluation

  • Bioanalytical Services

    Bioanalytical Services

    Bioanalytical Services

  • Pharmacokinetic Services

    Pharmacokinetic Services

    Pharmacokinetic Services

  • Pharmacology Services

    Pharmacology Services

    Pharmacology Services

  • Biology Services

    Biology Services

    Biology Services

  • Drug Formulation

    Drug Formulation

    Drug Formulation

  • Chemistry Services

    Chemistry Services

    chemistry

    Chemistry Services

    chemistry

Recent News

  • Discovery-on-Target-DOT

    Come and Join Medicilon at Booth # 114 in DOT

    Let’s Discover the Future of Novel Drugs and Technologies Together! Discovery on Target (DOT) 2021 Discovery

    Read More
  • Top-Chinese-RD-CRO-Enterprises-in-2021

    Medicilon is Listed on the “Top Chinese R&D CRO Enterprises in 2021”

    On the September 18th to 19th, the Smart China Expo’s important series of events, “2021 Conference

    Read More
  • the-21st-China-International-Fair-for-Investment-and-Trade

    Medicilon attended the 21st China International Fair for Investment and Trade

    Medicilon attended the 21st China International Fair for Investment and Trade and signed a strategic collaboration

    Read More
  • Medicilon's pharmacology models for inflammatory-immune diseases

    Targeting IL-23, Medicilon Assists the Development of a Variety of New Drugs for Psoriasis

    With people’s in-depth understanding of the inflammatory pathways of psoriasis, biologics continue to develop.  From tumor

    Read More

  • The 19th Annual San Diego BioPharma Conference

    Agenda 9:00 am Welcome and Opening Remarks Tao Wu, PhD, President, SABPA Yi Liu, PhD, Chair,

    Read More
  • Medicilon won the "Science and Technology Innovation Service Demonstration Case" Award

    Medicilon won the “Science and Technology Innovation Service Demonstration Case” Award

    During September 2 to 7, the 2021 China International Fair for Trade in Services (CIFTIS) co-sponsored

    Read More
  • Dr. Hong Wan as Vice President of Pharmacokinetics and Bioanalysis Department

    Medicilon appoints Dr. Hong Wan as Vice President of DMPK and Bioanalysis Department

    Recently, Shanghai Medicilon Inc. (stock code: 688202.SH) (Medicilon) announced the appointment of Dr. Hong Wan as

    Read More
  • Kumquat Biosciences and Eli Lilly have reached a partnership to jointly develop tumor immune small molecule drugs

    Kumquat Biosciences and Eli Lilly have reached a partnership to jointly develop tumor immune small molecule drugs

    Recently, Loxo Oncology, a research and development group of Eli Lilly, and Kumquat Biosciences (Kumquat) announced

    Read More

Interested in our expertise?

Let's Start the Conversation

Contact Us

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug Conjugate(ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • Medicilon Inhalation Formulation R&D Platform
      • Preclinical Ophthalmic Research Platform
      • mRNA Vaccine Bioanalysis Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • Medicilon Inhalation Formulation R&D Platform
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
      • Medicilon Metabolite Identification (MetlD) Service Platform
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc